Inhibition of Sodium Glucose Cotransporters Improves Cardiac Performance

The sodium-glucose cotransporter (SGLT) inhibitors represent a new alternative for treating patients with diabetes mellitus. They act primarily by inhibiting glucose reabsorption in the renal tubule and therefore, decreasing blood glucose levels. While little is yet known about SGLT subtype 1, SGLT2...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Ropero, Álvaro, Vargas-Delgado, Ariana P., Santos-Gallego, Carlos G., Badimon, Juan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651487/
https://www.ncbi.nlm.nih.gov/pubmed/31277431
http://dx.doi.org/10.3390/ijms20133289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6651487/
https://www.ncbi.nlm.nih.gov/pubmed/31277431
http://dx.doi.org/10.3390/ijms20133289

Ejemplares similares